Zobrazeno 1 - 10
of 4 866
pro vyhledávání: '"Bigner"'
Publikováno v:
Cancer Management and Research, Vol Volume 10, Pp 1329-1340 (2018)
Liyi Xie,1–3 Chen Lin,4 Qingfu Zhang,5 Hailan Piao,6 Darell D Bigner,3,7 Zhen Zhang,1,2 Xuhui Bao8 1Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; 2Department of Oncology, Shanghai Medical College, Fudan
Externí odkaz:
https://doaj.org/article/e2d0704b3ff44794a39f66e79ee4bef2
Autor:
Inés Fallon, Henar Hernando, Olga Almacellas-Rabaiget, Berta Marti-Fuster, Cesare Spadoni, Darell D Bigner, Eva Méndez
Publikováno v:
SLAS Discovery, Vol 29, Iss 2, Pp 100147- (2024)
Pediatric brain tumors (PBTs) represent about 25 % of all pediatric cancers and are the most common solid tumors in children and adolescents. Medulloblastoma (MB) is the most frequently occurring malignant PBT, accounting for almost 10 % of all pedia
Externí odkaz:
https://doaj.org/article/1e0ff29b0fe64186853cb03570fd049d
Autor:
Fallon, Inés, Hernando, Henar, Almacellas-Rabaiget, Olga, Marti-Fuster, Berta, Spadoni, Cesare, Bigner, Darell D, Méndez, Eva
Publikováno v:
In SLAS Discovery March 2024 29(2)
Autor:
Kuan Chien-Tsun, Wakiya Kenji, Herndon James E, Lipp Eric S, Pegram Charles N, Riggins Gregory J, Rasheed Ahmed, Szafranski Scott E, McLendon Roger E, Wikstrand Carol J, Bigner Darell D
Publikováno v:
BMC Cancer, Vol 10, Iss 1, p 468 (2010)
Abstract Background Glioblastoma multiforme (GBM) is refractory to conventional therapies. To overcome the problem of heterogeneity, more brain tumor markers are required for prognosis and targeted therapy. We have identified and validated a promisin
Externí odkaz:
https://doaj.org/article/4050fd110bde41c08086dc41dc2b1cd6
Autor:
Vogelstein Bert, Kopelovich Levy, Bigner Darell, Edwards Jennifer, Riggins Gregory J, Wang Tian-Li, Schaefer Carl F, Di Chunhui, Cummins Jordan, Lin Jimmy, Leary Rebecca J, Duncan Christopher G, Kinzler Kenneth W, Velculescu Victor E, Yan Hai
Publikováno v:
BMC Medical Genomics, Vol 2, Iss 1, p 22 (2009)
Abstract Background Microorganisms have been associated with many types of human diseases; however, a significant number of clinically important microbial pathogens remain to be discovered. Methods We have developed a genome-wide approach, called Dig
Externí odkaz:
https://doaj.org/article/e4313e5820034f49b5a1f7ed4ed1e08d
Autor:
Brendan Podszus, BS, Jessica Bigner, MD, Ramzy Ahmed, BS, Mia Cranmer, MS, Olivia Markert, BS, Lauren Trzcinski, BS, Grace Yi, MS, Yifan Guo, MD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 12, Iss S5, Pp 115-115 (2024)
Externí odkaz:
https://doaj.org/article/67afadde5f714238bc49ae8a275cc3c4
Autor:
Thompson, Eric M, Landi, Daniel, Brown, Michael C, Friedman, Henry S, McLendon, Roger, Herndon, James E, II, Buckley, Evan, Bolognesi, Dani P, Lipp, Eric, Schroeder, Kristin, Becher, Oren J, Friedman, Allan H, McKay, Zachary, Walter, Ashley, Threatt, Stevie, Jaggers, Denise, Desjardins, Annick, Gromeier, Matthias, Bigner, Darell D, Ashley, David M *
Publikováno v:
In The Lancet Child & Adolescent Health July 2023 7(7):471-478
Autor:
Daniel Landi, Annick Desjardins, Matthias Gromeier, Darell D Bigner, Smita K Nair, Michael C Brown, Georgia M Beasley, David M Ashley, Yuanfan Yang, Zachary P McKay, Dina M Randazzo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 4 (2023)
Background Antitumor mechanisms of CD4+ T cells remain crudely defined, and means to effectively harness CD4+ T-cell help for cancer immunotherapy are lacking. Pre-existing memory CD4+ T cells hold potential to be leveraged for this purpose. Moreover
Externí odkaz:
https://doaj.org/article/73dcacec3cd343d394456d6088d99ca1
Autor:
Arndt Borkhardt, Nan Qin, Stephen T Keir, Darell D Bigner, Allison Cole, Matthias Wölfl, Viktoria Marquardt, Johanna Theruvath, David Pauck, Daniel Picard, Lena Blümel, Mara Maue, Jasmin Bartl, Ulvi Ahmadov, Maike Langini, Frauke-Dorothee Meyer, Joselyn Cruz-Cruz, Claus M Graef, Till Milde, Olaf Witt, Anat Erdreich-Epstein, Gabriel Leprivier, Ulf Kahlert, Anja Stefanski, Kai Stühler, Julia Hauer, Thomas Beez, Christiane B Knobbe-Thomsen, Ute Fischer, Jörg Felsberg, Finn K Hansen, Rajeev Vibhakar, Sujatha Venkatraman, Samuel H Cheshier, Guido Reifenberger, Thomas Kurz, Marc Remke, Siddhartha Mitra
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 1 (2023)
Background While major advances have been made in improving the quality of life and survival of children with most forms of medulloblastoma (MB), those with MYC-driven tumors (Grp3-MB) still suffer significant morbidity and mortality. There is an urg
Externí odkaz:
https://doaj.org/article/bea518d410cc4fd58c33516272b055a1